Related Articles
Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells
Protein kinase C-α downregulates estrogen receptor-α by suppressing c-Jun phosphorylation in estrogen receptor-positive breast cancer cells
Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
Inhibition of platelet‑derived growth factor receptor synergistically increases the pharmacological effect of tamoxifen in estrogen receptor α positive breast cancer